RxDoctor Payments Data

Ashley Young

Acute Care · Washington, DCNPI 1336623099

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,269 of the $3,170 with a category attached, or 71.6%. Cvrx, Inc. accounts for 63.0% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $1,892, 5.8 times the $327 reported in 2021. Among acute care clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,170in general payments, 2019–2025

Across 29 payments — averaging $109.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cvrx, Inc.$2K
  • Abbott$427
  • Abiomed$271
  • Medtronic$218
  • Bridgebio Pharma, Inc.$142
  • Atricure, Inc.$45
  • plus $71 from 3 others

What the payments were for

  • Travel & lodging$90128%
  • Food & beverage$2,26972%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,170 in reported general payments places this provider in the 95th percentile of 110 acute care providers in District of Columbia.

See all acute care providers in District of Columbia

Medicare billing

Part B allowed, 2024
$6,028
Medicare patients
40
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin89$58,959
EntrestoSacubitril/Valsartan67$56,090
FarxigaDapagliflozin Propanediol14$7,630
Atrovent HfaIpratropium Bromide12$6,024
Bumetanide40$785
Warfarin Sodium56$592
Metoprolol Succinate56$469
Doxycycline Hyclate11$440
Spironolactone69$402
Carvedilol43$194
Hydralazine Hcl23$182
Atorvastatin Calcium33$150
Bupropion XlBupropion Hcl13$110
Pantoprazole Sodium32$103
Furosemide18$88

Paid to pharmacies, not to this prescriber.

Other acute care in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →